US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Pharmaceuticals: market research reports

  • Biopharmaceuticals (286)
  • Diseases & Conditions (3830)
  • Drug Delivery (293)
  • Therapeutic Area (7295)
  • Vaccines (728)
RSS Feeds

Pharmaceuticals market research reports and industry analysis

5  6  7  8    10    12  13  14  
Barr Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
4/15/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Barr Pharmaceuticals, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
$350.00
Tekmira Pharmaceuticals Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
4/15/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Tekmira Pharmaceuticals Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
$350.00
Oculus Innovative Sciences, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
4/15/2014 | published by: MarketLine
... the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Oculus Innovative Sciences, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, ...  |  read more...
$350.00
PAREXEL International Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
4/15/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' PAREXEL International Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
$350.00
Merck Sharp & Dohme Corp. (formerly Merck & Co., Inc.) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
4/15/2014 | published by: MarketLine
... reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Merck Sharp & Dohme Corp. (formerly Merck & Co., Inc.) Mergers ...  |  read more...
$350.00
PDL BioPharma, Inc. (formerly Protein Design Labs, Inc.) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
4/15/2014 | published by: MarketLine
... a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' PDL BioPharma, Inc. (formerly Protein Design Labs, Inc.) Mergers & Acquisitions (M&A), Partnerships ...  |  read more...
$350.00
Acceleron Pharma, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
4/15/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Acceleron Pharma, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
$350.00
F. Hoffmann-La Roche, Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
4/15/2014 | published by: MarketLine
... the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' F. Hoffmann-La Roche, Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, ...  |  read more...
$350.00
Atomic Spectroscopy Market by Technology ( X-Ray Fluorescence / Atomic Absorption / X-Ray Diffraction / ICP-MS ) & by Application ( Food & Beverage / Pharmaceutical / Industrial Chemistry / Biotechnology / Environment ) - Competitive Landscape - Global Fo
4/14/2014 | published by: MarketsandMarkets
... - Competitive Landscape - Global Forecasts & Trends to 2018 The global atomic spectroscopy market was valued at an estimated $4.02 billion in 2013 and is expected to grow at a CAGR of 6.4%. Various ...  |  read more...
$4,650.00
Cell Analysis Market by Instruments (Flow Cytometer, Microscope, Microfluidics, QPCR), Consumables, Application (Cell Identification, Cell Viability, Cell Proliferation, Cytology, Signal Transduction, Single Cell Analysis) - Global Forecast to 2018
4/14/2014 | published by: MarketsandMarkets
... is a technology-driven market and is marked by the ‘Threat of Obsolescence,’ wherein technologies as well as their adoption by end users changes very rapidly. Hospitals, academic and government institutes, as well as pharmaceutical and ...  |  read more...
$4,650.00
Pancreatic Adenocarcinoma Therapeutics in Major Developed Markets to 2019 - Early Stage Pipeline Shows Diversity of Novel Targets though Commercial Impact Remains Distant
4/14/2014 | published by: GBI Research
... latest research,‘Pancreatic Adenocarcinoma Therapeutics in Major Developed Markets to 2019 - Early Stage Pipeline Shows Diversity of Novel Targets though Commercial Impact Remains Distant’, which provides in-depth analysis of pancreatic adenocarcinoma market within the eight ...  |  read more...
$3,500.00
HIV Therapeutics in Major Developed Markets to 2019 - Limited Pipeline Efficacy Improvement, Patent Expirations and Stringent Healthcare Spending to Suppress Market Growth
4/14/2014 | published by: GBI Research
... latest research report, entitled,'HIV Therapeutics in Major Developed Markets to 2019 - Limited Pipeline Efficacy Improvement, Patent Expirations and Stringent Healthcare Spending to Suppress Market Growth'. The report provides insights into the HIV (Human Immunodeficiency ...  |  read more...
$3,500.00
Tissue Diagnostics Market by Technology (Immunohistochemistry, in Situ Hybridization, Digital pathology & Workflow, Special Staining), Disease (Breast Cancer, Gastric Cancer, Lymphoma, Prostate Cancer, Non Small Cell Lung Cancer and Others), Product (Inst
4/11/2014 | published by: MarketsandMarkets
... End-Users (Hospitals, Pharmaceutical companies, Research Laboratories, Contract Research Organizations and Others) & by Region (The Americas, Europe, BRIC, Japan & RoW) - Trends & Forecast to 2018 Tissue diagnostics is used to determine the stage, ...  |  read more...
$4,650.00
Vaccines: The End of Illness Overview
4/10/2014 | published by: CHI Insight Pharma Reports
... efficient healthcare. Their low cost, extended protection and the impossibility of their circumvention through development of resistance on the part of the target pathogen have been longstanding attributes of vaccines. Today, vaccine technology is undergoing ...  |  read more...
$2,495.00
Morocco Pharmaceuticals and Healthcare Report Q2 2014
4/9/2014 | published by: Business Monitor International
... in pharmaceuticalsales is starting to slow, indicating that conditions for Moroccan drugmakers are beginning to improve asthe growing middle class drives demand. Our outlook is therefore more positive over the long term. Meanwhile, the patented ...  |  read more...
$1,295.00
Saudi Arabia Pharmaceuticals and Healthcare Report Q2 2014
4/9/2014 | published by: Business Monitor International
... of factors. However, risks to ouroutlook are to the downside, some of which include greater-than-expected drops in the oil price, thegovernment's failure to deliver on healthcare infrastructure expansion and medicine price cuts in theshort term. ...  |  read more...
$1,295.00
Serbia Pharmaceuticals and Healthcare Report Q2 2014
4/9/2014 | published by: Business Monitor International
... unable to earn profits from the sale of these medicines, which is impacting patients. As thecountry continues its economic convergence with developed Europe, drug consumption is expected to rise. Meanwhile, financial inefficiencies within the health ...  |  read more...
$1,295.00
Chemical & Pharmaceutical Plant Construction in Indonesia to 2018: Market Databook
4/9/2014 | published by: Timetric
... chemical and pharmaceutical plant construction industry, including a breakdown of the data by construction activity (new construction, repair and maintenance, refurbishment and demolition). The databook provides historical and forecast valuations of the industry using the ...  |  read more...
$500.00
Sustained Release Ocular Drug Delivery Systems Market, 2014-2024
4/8/2014 | published by: Roots Analysis
... Several barriers have to be overcome for successful ocular drug delivery. For example, dilution of a drug by tears, clearance of a drug by the lymphatic system of conjunctiva, drug permeation issues with respect to ...  |  read more...
$1,899.00
Protein Hydrolysis Enzymes Market by Sources (Microorganisms, Animals, Plants), Applications (Detergent Industry, Pharmaceuticals, Food Industry and Others), & Geography (North America, Europe, Asia-Pacific & ROW) - Global Trends & Forecasts to 2019
4/8/2014 | published by: MarketsandMarkets
... which are very specific to protein hydrolysis are protease enzymes and they are classified under the “hydrolases group”. Protease enzymes refer to a group of enzymes whose catalytic function is to hydrolyze (breakdown) proteins. These ...  |  read more...
$4,650.00
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Indonesia
4/7/2014 | published by: GlobalData
... on and analysis of the healthcare, regulatory and reimbursement landscape in Indonesia, identifying key trends in the healthcare market and providing insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure. Most importantly, the report ...  |  read more...
$1,995.00
Conference Documentation: Biosimilars and Biobetters USA
4/7/2014 | published by: SMI Publishing, Ltd
... Hotel, Iselin, NJ. Following on from the phenomenal success of a portfolio of international pharmaceutical events, including our flagship annual European Biosmilars and Biobetters conference, we bring you this exciting, timely and important conference. As the ...  |  read more...
$788.78
Top 25 Pharmaceutical Company Pipeline Analysis and Sales Projections to 2023
4/7/2014 | published by: Kalorama Information
... late-term pipeline of major companies. This report provides long-term company sales forecasts which are based on 2013 market conditions. For each company, the report provides: Revenues R&D Spending 2007-2013 Geographic Breakout of Revenues Performance of ...  |  read more...
$3,995.00
Psoriasis Market Info™- Customized Report
4/4/2014 | published by: Drug Market Info
 |  read more...
$13,250.00
Global Hypertension Drugs Market 2014-2018
4/4/2014 | published by: Infiniti Research Limited - TechNavio
... Lifestyle habits such as diet, exercising, and smoking are the major causes of hypertension. Hypertension can damage organs and lead to several illnesses such as renal failure, aneurysm, heart failure, stroke, and heart attack. There ...  |  read more...
$2,500.00
5  6  7  8    10    12  13  14  
 
Our Clients